Skip to main content

Table 4 Demographic and baseline characteristics for PP population

From: Statistical analysis plan for an international, double-blind, randomized controlled clinical trial on the use of phantom motor execution as a treatment for phantom limb pain

Baseline characteristics to be reported by treatment group (PP population)

n(%) unless otherwise specified

PME (n=)

PMI (n=)

Overall (n=)

Background information

Age at randomization [years, mean (SD)]

   

Sex [% male]

   

Time since amputation [months, mean (SD)]

   

Time since onset of PLP [months, mean (SD)]

   

Reason of amputation

trauma

   

cardiovascular

   

cancer

   

other

   

Type of prosthesis

none

   

active/myoelectric

   

cosmetic

   

passive

   

body-powered

   

Daily prosthesis use [hours, mean (SD)]

   

Minimization factors

Level of amputation

upper limb

   

lower limb

   

Intensity of PLP [NRS (0-10), mean(SD)]

high (> 4)

   

low (<= 4)

   

Investigational site

#1

   

#2

   

#3

   

#4

   

#5

   

#6

   

#7

   

#8

   

#9

   

Chosen treatment frequency

once a week

   

twice a week

   

five times a week

   

Q-PLP

Intensity of stump pain [range, mean (SD)]

   

Intensity of PLS [range, mean (SD)]

   

Intensity of voluntary phantom movements [range, mean (SD)]

   

PRI at baseline range, mean (SD)]

   

Pain interference with sleep [range, mean (SD)]:

   

Pain interference with daily life activities [range, mean (SD)]:

   

Pain interference with work [range, mean (SD)]:

   

Presence of telescoping [range, mean (SD)]

   

Weighted Pain Distribution Index [range, mean (SD)]:

   

Other questionnaires

PDI [range, mean (SD)]:

   

EQ5D-5L [range, mean (SD)]:

   

PSEQ-2 [range, mean (SD)]:

   

PCS-SF [range, mean (SD)]:

   

PHQ-2 [range, mean (SD)]:

   

EXPECT-SF [range, mean (SD)]:

   
  1. Abbreviations: PME Phantom Motor Execution, PMI Phantom Motor Imagery, PLP Phantom Limb Pain, NRS Numeric Rate Scale, Q-PLP Questionnaire for Phantom Limb Pain, PDI Pain Disability Index, PSEQ-2 2-item Pain Self-Efficacy Questionnaire, EQ-5D-5L Euroqol-5D-5L, PCS-SF Pain Catastrophizing Scale Short Form, PHQ-2 2-item Patient Health Questionnaire, PGIC Patients' Global Impression of Change, OAT Opinion About Treatment, HCCQ Health Care Climate Questionnaire and EXPECT-SF Expectations for Complementary and Alternative Medicine Treatments Short Form